Sunshine Biopharma Inc. -27SBFMWPreferred / convertible
13F holders, Q4 2024 (December 31)2holders
0new positions
0sold out
1famous investor
$0.16avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Sunshine Biopharma Inc. -27 (SBFMW) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($7K) and UBS Group AG ($208). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Sunshine Biopharma Inc. -27
- CUSIP
- 867781502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 4,300 shares sold, net −4,300 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Reduce -8.2% | 41,431 | $7K |
| UBS Group AG | — | Reduce -31.8% | 1,289 | $208 |
"% of holder's portfolio" is SBFMW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. -27 the manager owns.